Fig. 3: Anti-ZIKV IgG and neutralising antibodies pre and post ZIKV challenge. | npj Vaccines

Fig. 3: Anti-ZIKV IgG and neutralising antibodies pre and post ZIKV challenge.

From: Passive immunisation of convalescent human anti-Zika plasma protects against challenge with New World Zika virus in cynomolgus macaques

Fig. 3

Sera collected over the time-course were assessed for their anti-ZIKV activity using (a) whole virus anti-ZIKV IgG (b) binding antibody levels to anti-NS-1 IgG expressed as relative units (RU)/mL, (c) neutralisation titres expressed in International Units (IU/mL) Treatment macaques (Group A) are depicted in green and challenge controls (Group B) in red. Arrow indicates administration of the virus.

Back to article page